RESUMEN
Caenorhabditis elegans, a kind of model organism, was used to investigate biodegradation pathway of IPP and M1 in nematodes, in vivo toxicity from IPP and M1 and the possible underlying molecular mechanism. The results showed that both IPP and M1 could decrease lifespan, locomotion behavior, reproductive ability and AChE activity. During IPP biodegradation process, three intermediates (M1-M3) were monitored and identified. Based on the identified metabolites and their biodegradation courses, a possible biodegradation pathway was proposed. IPP was probably transformed to different three metabolites in nematodes through oxidation and elimination of methyl and propyl etc. Under the same concentration, IPP had more severe toxicity than M1 on nematodes. IPP and M1 might reduce lifespan and decrease reproductive ability through influencing insulin/IGF signaling pathway and TOR signaling pathway. They could decrease expression levels of daf-16, sgk-1, aak-2, daf-15 and rict-1 genes, which involved in IGF and TOR signaling pathway.
Asunto(s)
Compuestos de Azabiciclo , Caenorhabditis elegans , Insecticidas , Piridinas , Animales , Acetilcolinesterasa/metabolismo , Compuestos de Azabiciclo/toxicidad , Biodegradación Ambiental , Caenorhabditis elegans/efectos de los fármacos , Caenorhabditis elegans/metabolismo , Proteínas de Caenorhabditis elegans/genética , Proteínas de Caenorhabditis elegans/metabolismo , Regulación de la Expresión Génica , Insecticidas/toxicidad , Longevidad/efectos de los fármacos , Piridinas/toxicidad , Reproducción/efectos de los fármacos , Transducción de Señal , Somatomedinas/genética , Somatomedinas/metabolismoRESUMEN
A series of novel 1'-[2-(difluoromethoxy)benzyl]-2'H,5'H-spiro[8-azabicyclo[3.2.1]octane-3,4'-imidazolidine]-2',5'-dione substituted hydantoins (5-32) were synthesized using an appropriate synthetic route and characterized by elemental analysis and spectral data. The novel molecules were screened for anticonvulsant activity in mice by maximal electroshock (MES) and subcutaneous pentylenetetrazol (ScPTZ)-induced seizure tests. The neurotoxicity was assessed using the rotarod method. Compounds 9, 10, 18, 30, and 31 exhibited anticonvulsant potency against MES seizure and in the ScPTZ model, with lesser neurotoxicity. Some title compounds showed lesser central nervous system depression compared to phenytoin.
Asunto(s)
Anticonvulsivantes/síntesis química , Compuestos de Azabiciclo/síntesis química , Imidazolidinas/síntesis química , Compuestos de Espiro/síntesis química , Animales , Anticonvulsivantes/química , Anticonvulsivantes/uso terapéutico , Anticonvulsivantes/toxicidad , Compuestos de Azabiciclo/química , Compuestos de Azabiciclo/uso terapéutico , Compuestos de Azabiciclo/toxicidad , Conducta Animal/efectos de los fármacos , Imidazolidinas/química , Imidazolidinas/uso terapéutico , Imidazolidinas/toxicidad , Masculino , Ratones , Estructura Molecular , Actividad Motora/efectos de los fármacos , Prueba de Desempeño de Rotación con Aceleración Constante , Convulsiones/tratamiento farmacológico , Compuestos de Espiro/química , Compuestos de Espiro/uso terapéutico , Compuestos de Espiro/toxicidadRESUMEN
BACKGROUND: SCH 486757 is a nociceptin-1 receptor agonist that was in development as an antitussive. Studies were conducted to characterize its effects on female fertility and to examine its potential modes of action. METHODS: Female rats were administered up to 20 mg/kg SCH 486757 before/during mating through gestation day (GD) 7; female fertility and embryonic development were assessed on GD 14. In a subsequent study, pregnant rats were dosed up to 50 mg/kg SCH 486757 from GD 0 to 7. Reproductive hormones were assessed on GD 1, 3, 5, and 7, and embryonic development was assessed on GD 14. A subset of dosed dams were allowed to deliver, were subsequently re-mated, and reproductive hormones and fertility were assessed on GD 7 and 14, respectively. To determine the effects of SCH 486757 on nonpregnant rats, doses of up to 50 mg/kg SCH 486757 were administered for 4 days beginning on the day of estrus; reproductive hormones were assessed after the final dose. RESULTS: Female rats administered ≥20 mg/kg SCH 486757 exhibited abnormal estrous cycles; decreased fertility, number of corpora lutea, and implantation sites; and increased pre- and postimplantation loss. In general, administration of SCH486757 was associated with lower luteinizing hormone (LH) progesterone (P4), and estradiol (E2) levels in pregnant rats. These effects on fertility/embryonic development and reproductive hormones exhibited reversibility post dosing. Nonpregnant rats in the 50-mg/kg group exhibited apparent decreases in P4 and E2 levels, with no apparent effects on LH values. CONCLUSIONS: The SCH 486757-related effects on fertility and embryonic development were likely the result of decreases in P4, E2, and/or LH, rather than being due to decreased prolactin levels.
Asunto(s)
Compuestos de Azabiciclo/toxicidad , Fertilidad/efectos de los fármacos , Hormonas/sangre , Pirimidinas/toxicidad , Receptores Opioides/agonistas , Reproducción/efectos de los fármacos , Animales , Peso Corporal/efectos de los fármacos , Cesárea , Ciclo Estral/efectos de los fármacos , Femenino , Masculino , Embarazo , Ratas , Receptores Opioides/metabolismo , Conducta Sexual Animal/efectos de los fármacos , Análisis de Supervivencia , Receptor de NociceptinaRESUMEN
N-alkyl-N-methylmorpholinium and N-alkyl substituted 1,4-diazabicyclo[2.2.2]octane (DABCO) based ionic liquids (ILs), N-alkyl-DABCO, bearing short alkyl chains are characterised by a low toxicity to Vibrio fischeri, although toxicity significantly increases on increasing the alkyl chain length. Alkyl chain length affects also biodegradability in the 28 days tests; the higher level of biodegradation was found in both the series in the case of the ethyl (C2) derivatives. In the case of N-ethyl DABCO based IL, although biodegradability is still around 40%, and consequently this IL cannot be classified as "readily biodegradable", this value is similar to the more biodegradable functionalized imidazolium based ILs.
Asunto(s)
Aliivibrio fischeri/efectos de los fármacos , Compuestos de Azabiciclo/toxicidad , Líquidos Iónicos/toxicidad , Morfolinas/toxicidad , Contaminantes Químicos del Agua/toxicidad , Compuestos de Azabiciclo/metabolismo , Biodegradación Ambiental , Líquidos Iónicos/metabolismo , Morfolinas/metabolismo , Piperazinas/metabolismo , Piperazinas/toxicidad , Pruebas de Toxicidad Aguda , Contaminantes Químicos del Agua/metabolismoRESUMEN
Dialkylaminoalkyl derivatives of 2-azabicyclo[3.2.2]nonanes and of bicyclo[2.2.2]octanes were prepared and their activities determined in vitro against the multiresistant K1 strain of Plasmodium falciparum. Several of the new compounds exhibited very promising antiplasmodial activity and selectivity. The results were compared to those of formerly synthesized analogues and of drugs in use. Structure-activity relationships were detected. Some of the more potent compounds were tested in vivo against Plasmodium berghei showing weak to moderate activity. A single compound was able to increase the mean survival days of infected mice.
Asunto(s)
Antimaláricos/farmacología , Compuestos de Azabiciclo/química , Compuestos Bicíclicos con Puentes/química , Animales , Antimaláricos/química , Antimaláricos/toxicidad , Compuestos de Azabiciclo/síntesis química , Compuestos de Azabiciclo/toxicidad , Compuestos Bicíclicos con Puentes/síntesis química , Compuestos Bicíclicos con Puentes/toxicidad , Modelos Animales de Enfermedad , Ratones , Mioblastos Esqueléticos/efectos de los fármacos , Plasmodium berghei/efectos de los fármacos , Plasmodium falciparum/efectos de los fármacos , Ratas , Relación Estructura-ActividadRESUMEN
Mu-opioid analgesics are a mainstay in the treatment of acute and chronic pain of multiple origins, but their side effects, such as constipation, respiratory depression, and abuse liability, adversely affect patients. The recent demonstration of the up-regulation and membrane targeting of the delta-opioid receptor (DOR) following inflammation and the consequent enhanced therapeutic effect of delta-opioid agonists have enlivened the search for delta-opioid analgesic agents. JNJ-20788560 [9-(8-azabicyclo-[3.2.1]oct-3-ylidene)-9H-xanthene-3-carboxylic acid diethylamide] had an affinity of 2.0 nM for DOR (rat brain cortex binding assay) and a naltrindole sensitive DOR potency of 5.6 nM (5'-O-(3-[(35)S]thio)triphosphate assay). The compound had a potency of 7.6 mg/kg p.o. in a rat zymosan radiant heat test and of 13.5 mg/kg p.o. in a rat Complete Freund's adjuvant RH test but was virtually inactive in an uninflamed radiant heat test. In limited studies, tolerance was not observed to the antihyperalgesic or antinociceptive effects of the compound. Unlike ibuprofen, JNJ-20788560 did not produce gastrointestinal (GI) erosion. Although morphine reduced GI motility at all doses tested and reached nearly full effect at the highest dose, JNJ-20788560 did not retard transit at the lowest dose and reached only 11% reduction at the highest dose administered. Unlike morphine, JNJ-20788560 did not exhibit respiratory depression (blood gas analysis), and no withdrawal signs were precipitated by the administration of opioid (mu or delta) antagonists. Coupled with the previously published lack of self-administration behavior of the compound by alfentanil-trained primates, these findings strongly recommend delta-opioid agonists such as JNJ-20788560 for the relief of inflammatory hyperalgesia.
Asunto(s)
Analgésicos Opioides , Compuestos de Azabiciclo/farmacología , Hiperalgesia/tratamiento farmacológico , Receptores Opioides delta/agonistas , Insuficiencia Respiratoria/inducido químicamente , Trastornos Relacionados con Sustancias/fisiopatología , Xantenos/farmacología , Alfentanilo/farmacología , Animales , Compuestos de Azabiciclo/efectos adversos , Compuestos de Azabiciclo/toxicidad , Cricetinae , Tolerancia a Medicamentos , Motilidad Gastrointestinal/efectos de los fármacos , Guanosina 5'-O-(3-Tiotrifosfato)/metabolismo , Calor , Irritantes/toxicidad , Masculino , Ratones , Dimensión del Dolor/efectos de los fármacos , Ratas , Ratas Wistar , Receptores Opioides delta/metabolismo , Insuficiencia Respiratoria/fisiopatología , Convulsiones/inducido químicamente , Autoadministración , Úlcera Gástrica/inducido químicamente , Úlcera Gástrica/patología , Síndrome de Abstinencia a Sustancias/psicología , Xantenos/efectos adversos , Xantenos/toxicidad , ZimosanRESUMEN
Multidrug-resistant (MDR) bacterial infections are a serious threat to public health. Among the most alarming resistance trends is the rapid rise in the number and diversity of ß-lactamases, enzymes that inactivate ß-lactams, a class of antibiotics that has been a therapeutic mainstay for decades. Although several new ß-lactamase inhibitors have been approved or are in clinical trials, their spectra of activity do not address MDR pathogens such as Acinetobacter baumannii. This report describes the rational design and characterization of expanded-spectrum serine ß-lactamase inhibitors that potently inhibit clinically relevant class A, C and D ß-lactamases and penicillin-binding proteins, resulting in intrinsic antibacterial activity against Enterobacteriaceae and restoration of ß-lactam activity in a broad range of MDR Gram-negative pathogens. One of the most promising combinations is sulbactam-ETX2514, whose potent antibacterial activity, in vivo efficacy against MDR A. baumannii infections and promising preclinical safety demonstrate its potential to address this significant unmet medical need.
Asunto(s)
Acinetobacter baumannii/efectos de los fármacos , Compuestos de Azabiciclo/química , Compuestos de Azabiciclo/farmacología , Bacterias Gramnegativas/efectos de los fármacos , Inhibidores de beta-Lactamasas/química , Inhibidores de beta-Lactamasas/farmacología , Infecciones por Acinetobacter/tratamiento farmacológico , Infecciones por Acinetobacter/microbiología , Animales , Compuestos de Azabiciclo/uso terapéutico , Compuestos de Azabiciclo/toxicidad , Carbapenémicos/farmacología , Perros , Diseño de Fármacos , Evaluación Preclínica de Medicamentos , Farmacorresistencia Bacteriana Múltiple , Enterobacteriaceae/efectos de los fármacos , Infecciones por Bacterias Gramnegativas/tratamiento farmacológico , Humanos , Ratones , Modelos Moleculares , Proteínas de Unión a las Penicilinas/antagonistas & inhibidores , Ratas , Sulbactam/química , Sulbactam/farmacología , Inhibidores de beta-Lactamasas/uso terapéutico , Inhibidores de beta-Lactamasas/toxicidad , beta-Lactamasas/metabolismo , beta-Lactamas/farmacologíaRESUMEN
Soil enzyme activity and microbial population play important roles in maintaining soil fertility and ensure crop yield. Paichongding (IPP) is a novel cis-nitromethylene neonicotinoid insecticide, which was recently developed in China. In this study, in order to better understand IPP ecological toxicity, the impact of IPP on soil enzyme activity and microbial population in soils was investigated. The results showed that, urease activity was inhibited by IPP before 75 days incubation, after that this inhibiting effect gradually weakened. IPP had different stimulating effects on the activities of dehydrogenase, protease, and catalase. They were consistently stimulated from the initial time in soils. The results of microbial population indicated that the number of bacteria increased after IPP application compared with the control, fungal number increased before 45 days incubation and then decreased. While actinomycete number decreased during degradation period. DT50 (half-life value), k (degradation rate constant) of IPP in S1 (yellow loam soil), and S2 (Huangshi soil) were found 90 days and 173 days, 0.0077 day(-1), and 0.0040 day(-1), respectively.
Asunto(s)
Compuestos de Azabiciclo/toxicidad , Enzimas/análisis , Insecticidas/toxicidad , Piridinas/toxicidad , Microbiología del Suelo , Suelo/química , Actinobacteria/metabolismo , Bacterias/metabolismo , Biodegradación Ambiental , China , Hongos/metabolismo , Semivida , Oxidorreductasas/metabolismo , Contaminantes del SueloRESUMEN
INTRODUCTION: Preclinical assessment of the heart rate corrected QT interval (QTc) is an important component of the cardiovascular safety evaluation in drug discovery. Here we aimed to quantify the translational relationship between QTc prolongation and shortening in the conscious telemetered dog and humans by a retrospective pharmacokinetic-pharmacodynamic (PKPD) analysis. METHODS: QTc effects of 2 proprietary compounds and 2 reference drugs (moxifloxacin and dofetilide) were quantified in conscious dogs and healthy volunteers via a linear and Emax pharmacokinetic-pharmacodynamic models. The translational relationship was quantified by correlating the QTc response from dog and human at matching free drug concentrations. RESULTS: A consistent translational relationship was found at low delta-QTc intervals indicating that a QTc change of 2.5-8 ms in dog would correspond to a 10 ms change in human. DISCUSSION: The translational relationship developed here can be used to predict the QTc liability in human using preclinical dog data. It could therefore help protect the health of human volunteers, for example by appropriate clinical study design and dose selection, as well as improve future decision-making and help reduce compound attrition due to changes in QT interval.
Asunto(s)
Compuestos Aza/farmacocinética , Síndrome de QT Prolongado/inducido químicamente , Modelos Biológicos , Fenetilaminas/farmacocinética , Quinolinas/farmacocinética , Sulfonamidas/farmacocinética , Adulto , Animales , Compuestos Aza/toxicidad , Compuestos de Azabiciclo/farmacocinética , Compuestos de Azabiciclo/toxicidad , Bencimidazoles/farmacocinética , Bencimidazoles/toxicidad , Carbamatos/farmacocinética , Carbamatos/toxicidad , Ensayos Clínicos Fase I como Asunto , Perros , Método Doble Ciego , Evaluación Preclínica de Medicamentos/métodos , Electrocardiografía , Femenino , Fluoroquinolonas , Humanos , Masculino , Persona de Mediana Edad , Moxifloxacino , Fenetilaminas/toxicidad , Quinolinas/toxicidad , Ensayos Clínicos Controlados Aleatorios como Asunto , Estudios Retrospectivos , Especificidad de la Especie , Sulfonamidas/toxicidad , Telemetría , Investigación Biomédica Traslacional , Adulto JovenRESUMEN
BACKGROUND: IPP-10 is a novel neonicotinoid insecticide recently developed in China and has good activity against sucking insects. Studies were carried out to investigate the activity of IPP-10 against Rhopalosiphum padi L. RESULTS: The results demonstrated that IPP-10 had both contact and systemic activity, including acropetal and basipetal translocation in wheat vascular bundles. Starved R. padi were allowed to stay on wheat treated with a sublethal dose of IPP-10. The results of studying their feeding behaviour from an electrical penetration graph (EPG) revealed a decrease in total time and bout duration of xylem and phloem ingestion, but the total time and bout duration of phloem salivation were significantly prolonged. The frequency (7.03 +/- 0.49 Hz) of the xylem ingestion waveform produced by aphids on wheat treated with IPP-10 was significantly lower than that of blank control aphids (8.20 +/- 0.30 Hz). Consequently, aphids born on wheat treated with IPP-10 were obviously lighter and less fecund than the control aphids. CONCLUSION: These tests indicated that IPP-10 had both contact and systemic activity, with sublethal effects resulting in reduction in R. padi feeding behaviour, growth rate and fecundity.